These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 15993051

  • 1. The role of surgery in the management of gastrointestinal stromal tumors (GISTs) in the era of imatinib mesylate effectiveness.
    Kosmadakis N, Visvardis EE, Kartsaklis P, Tsimara M, Chatziantoniou A, Panopoulos I, Erato P, Capsambelis P.
    Surg Oncol; 2005 Aug; 14(2):75-84. PubMed ID: 15993051
    [Abstract] [Full Text] [Related]

  • 2. Gastric GIST: a single institutional retrospective experience with surgical treatment for primary disease.
    An JY, Choi MG, Noh JH, Sohn TS, Kang WK, Park CK, Kim S.
    Eur J Surg Oncol; 2007 Oct; 33(8):1030-5. PubMed ID: 17428635
    [Abstract] [Full Text] [Related]

  • 3. Surgery for gastrointestinal stromal tumour in the post-imatinib era.
    Neuhaus SJ, Clark MA, Hayes AJ, Thomas JM, Judson I.
    ANZ J Surg; 2005 Mar; 75(3):165-72. PubMed ID: 15777399
    [Abstract] [Full Text] [Related]

  • 4. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
    Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW.
    Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
    [Abstract] [Full Text] [Related]

  • 5. Management of gastrointestinal stromal tumors in the imatinib era: selected case studies.
    Benjamin RS, Blanke CD, Blay JY, Bonvalot S, Eisenberg B.
    Oncologist; 2006 Jan; 11(1):9-20. PubMed ID: 16401709
    [Abstract] [Full Text] [Related]

  • 6. Gastrointestinal stromal tumors.
    von Mehren M, Watson JC.
    Hematol Oncol Clin North Am; 2005 Jun; 19(3):547-64, vii. PubMed ID: 15939196
    [Abstract] [Full Text] [Related]

  • 7. Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatment.
    Yeh CN, Chen TW, Tseng JH, Liu YY, Wang SY, Tsai CY, Chiang KC, Hwang TL, Jan YY, Chen MF.
    J Surg Oncol; 2010 Nov 01; 102(6):599-603. PubMed ID: 20976730
    [Abstract] [Full Text] [Related]

  • 8. Two cases of complete response after imatinib mesylate treatment of advanced GIST.
    Papaxoinis G, Nikolaou M, Lianos E, Gaglia A, Economopoulos T, Pectasides D.
    Anticancer Res; 2006 Nov 01; 26(6C):4869-72. PubMed ID: 17214353
    [Abstract] [Full Text] [Related]

  • 9. Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era.
    Bonvalot S, Eldweny H, Péchoux CL, Vanel D, Terrier P, Cavalcanti A, Robert C, Lassau N, Cesne AL.
    Ann Surg Oncol; 2006 Dec 01; 13(12):1596-603. PubMed ID: 16957966
    [Abstract] [Full Text] [Related]

  • 10. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate.
    McAuliffe JC, Lazar AJ, Yang D, Steinert DM, Qiao W, Thall PF, Raymond AK, Benjamin RS, Trent JC.
    Clin Cancer Res; 2007 Nov 15; 13(22 Pt 1):6727-34. PubMed ID: 18006774
    [Abstract] [Full Text] [Related]

  • 11. Gastrointestinal stromal tumors (GISTs): a pathology view point.
    Sornmayura P.
    J Med Assoc Thai; 2009 Jan 15; 92(1):124-35. PubMed ID: 19260254
    [Abstract] [Full Text] [Related]

  • 12. Imatinib mesylate treatment for advanced gastrointestinal stromal tumor: a pilot study focusing on patients experiencing sole liver metastasis after a prior radical resection.
    Zhu J, Wang Y, Hou M, Li HY, Zhang J.
    Oncology; 2007 Jan 15; 73(5-6):324-7. PubMed ID: 18497504
    [Abstract] [Full Text] [Related]

  • 13. [Gastrointestinal stromal tumour: our experience].
    Versaci A, Macrì A, Ieni A, Terranova M, Leonello G, Saladino E, Speciale G, Famulari C.
    Chir Ital; 2009 Jan 15; 61(2):161-9. PubMed ID: 19536989
    [Abstract] [Full Text] [Related]

  • 14. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
    Rutkowski P, Debiec-Rychter M, Nowecki ZI, Wozniak A, Michej W, Limon J, Siedlecki JA, Jerzak Vel Dobosz A, Grzesiakowska U, Nasierowska-Guttmejer A, Sygut J, Nyckowski P, Krawczyk M, Ruka W.
    Med Sci Monit; 2007 Nov 15; 13(11):CR515-522. PubMed ID: 17968300
    [Abstract] [Full Text] [Related]

  • 15. [Current aspects of treatment in gastrointestinal stromal tumors (GIST)].
    Láng I, Hitre E.
    Orv Hetil; 2005 May 01; 146(18 Suppl 1):935-41. PubMed ID: 15921308
    [Abstract] [Full Text] [Related]

  • 16. [Treatment strategy for marginally resectable GIST].
    Kanda T, Ishikawa T, Ozaki T, Yajima K, Kosugi S, Hatakeyama K.
    Gan To Kagaku Ryoho; 2011 Aug 01; 38(8):1266-70. PubMed ID: 21829064
    [Abstract] [Full Text] [Related]

  • 17. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A, den Bakker MA, van Geel AN, Eggermont AM, Sleijfer S, Verweij J, de Wilt JH, Verhoef C.
    Anticancer Drugs; 2008 Jul 01; 19(6):607-12. PubMed ID: 18525320
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant imatinib treatment after R0 resection for patients with high-risk gastrointestinal stromal tumors: a median follow-up of 44 months.
    Jiang WZ, Guan GX, Lu HS, Yang YH, Kang DY, Huang HG.
    J Surg Oncol; 2011 Dec 01; 104(7):760-4. PubMed ID: 21713778
    [Abstract] [Full Text] [Related]

  • 19. [Peritoneal dissemination from gastrointestinal stromal tumor of small intestine responding completely to imatinib mesylate (STI 571)].
    Yamanaka H, Mizushima T, Mikata S, Ito T, Nonaka K, Ide H, Michiura T, Kainuma S, Iwase K.
    Gan To Kagaku Ryoho; 2005 Dec 01; 32(13):2125-8. PubMed ID: 16352942
    [Abstract] [Full Text] [Related]

  • 20. Large duodenal gastrointestinal stromal tumor presenting with acute bleeding managed by a whipple resection. A review of surgical options and the prognostic indicators of outcome.
    Machado NO, Chopra PJ, Al-Haddabi IH, Al-Qadhi H.
    JOP; 2011 Mar 09; 12(2):194-9. PubMed ID: 21386652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.